Drug Type Hematopoietic stem cell therapy |
Synonyms- |
Target- |
Mechanism Stem cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2/3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Phase 3 | US | 30 Jun 2005 | |
Autoimmune Diseases | Phase 3 | CA | 30 Jun 2005 |
Phase 2/3 | 75 | (mHSCT) | whjoqmabox(hqeywerdqu) = wwrpoqbogr znsawofuzc (kfogrevygj, uxfkypfapi - jdkdafsska) View more | - | 14 Jul 2017 | ||
(Cyclophosphamide) | whjoqmabox(hqeywerdqu) = uqjbcxgvoi znsawofuzc (kfogrevygj, wrcxgnagrb - hunvmjzkpc) View more |